What is RNTX's stock issuance proceeds?

RNTX (RNTX) reported stock issuance proceeds of $354K in Q1 2026.

How has RNTX's stock issuance proceeds changed year-over-year?

RNTX's stock issuance proceeds decreased by 52.0% year-over-year, from $737K to $354K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

RNTX RNTX Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Gilead SciencesGILD

$166M-34.1%

CTO

Citius Oncology, Inc.CTOR

$15.13M—

Ethos Technologies, Inc. LIFE

$0-100%

Gyre Therapeutics, Inc.GYRE

$21K-95.9%

LQD

Liquidia CorporationLQDA

$1.75M+38.6%

United TherapeuticsUTHR

$68.3M+311%

Other financials

Income statement

See full

Revenue-—

Operating income-$5.2M+6.8%

Net income-$5.8M-6.1%

EPS (diluted)-$0.19+24.0%

Balance sheet

See full

Cash & equivalents$4.4M-40.2%

Total debt$48.0K0.0%

Total equity$6.9M-63.0%

Total assets$26.3M-54.4%

Cash flow

See full

Operating cash flow-$3.4M+44.6%

CapEx-—

Free cash flow-$6.3M—

Valuation

See full

Market cap$88.96M+164%

Returns & leverage

See full

Return on equity-123.3%+86.1pp

Debt / equity0×0.0×

Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is RNTX's stock issuance proceeds?: RNTX (RNTX) reported stock issuance proceeds of $354K in Q1 2026.
How has RNTX's stock issuance proceeds changed year-over-year?: RNTX's stock issuance proceeds decreased by 52.0% year-over-year, from $737K to $354K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.